20.07.2015 Views

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

104pathogenicity of NDM- and non-NDM-carry<strong>in</strong>g stra<strong>in</strong>s. However, therapywith imipenem reduced the mortality of larvae <strong>in</strong>fected with non-NDMstra<strong>in</strong>s significantly. In contrast, imipenem <strong>in</strong>jection did not lowermortality rates of larvae <strong>in</strong>fected with NDM stra<strong>in</strong>s.Conclusion: The majority of imipenem-resistant stra<strong>in</strong>s carried the OXA-23 gene. The NDM-1 gene could already be detected <strong>in</strong> isolates from2007, two years before NDM-1 was <strong>in</strong>itially discovered. The first NDMmutant, NDM-2, was discovered <strong>in</strong> an isolate from 2010. With the use ofGalleria mellonella, we established an <strong>in</strong>fection model for evaluat<strong>in</strong>gpathogenicity and antibiotic treatment.MPV005Intim<strong>in</strong> and <strong>in</strong>vas<strong>in</strong> export their C-term<strong>in</strong>us to the bacterialcell surface us<strong>in</strong>g an <strong>in</strong>verse mechanism compared to classicalautotransportP. Oberhett<strong>in</strong>ger* 1 , M. Schütz 1 , J. Leo 2 , D. L<strong>in</strong>ke 2 , I. Autenrieth 11 Institute of Microbiology and Infection Medic<strong>in</strong>e, Medical Microbiology,Tüb<strong>in</strong>gen, Germany2 Max Planck Institute for Developmental Microbiology, Prote<strong>in</strong> Evolution,Tüb<strong>in</strong>gen, GermanyA large group of bacterial surface prote<strong>in</strong>s is represented by the family ofautotransporter prote<strong>in</strong>s, which belong to the type V secretion system andare found <strong>in</strong> almost all Gram-negative bacteria. Autotransporter prote<strong>in</strong>sare often important virulence factors and consist of three functionaldoma<strong>in</strong>s: a N-term<strong>in</strong>al signal sequence, a C-term<strong>in</strong>al translocator doma<strong>in</strong>and a passenger doma<strong>in</strong> <strong>in</strong> between. After synthesis <strong>in</strong> the cytosol and Secmediatedtransport across the <strong>in</strong>ner membrane <strong>in</strong>to the periplasm, thetranslocator doma<strong>in</strong> forms a beta-barrel pore <strong>in</strong> the outer membrane,presumably with the help of the Bam complex. Through this pore, thepassenger doma<strong>in</strong> is then translocated to the surface of the cell.A second, unrelated family of outer membrane prote<strong>in</strong>s that exposepassenger doma<strong>in</strong>s on the bacterial outer surface are the <strong>in</strong>tim<strong>in</strong>s and<strong>in</strong>vas<strong>in</strong>s, nonfimbrial adhes<strong>in</strong>s from pathogenic bacteria, whichspecifically <strong>in</strong>teract with host cell surface receptors and mediate bacterialattachment or <strong>in</strong>vasion. They are <strong>in</strong>tegrated <strong>in</strong>to the bacterial outermembrane with the am<strong>in</strong>o-term<strong>in</strong>al region, while the carboxy-term<strong>in</strong>alregion of the polypeptide is exposed on the bacterial outer membrane.Whereas the surface-localized parts of the prote<strong>in</strong> are functionally welldescribed, the topology and <strong>in</strong>sertion of the N-term<strong>in</strong>al membrane doma<strong>in</strong>and the translocation process have not been described. To <strong>in</strong>vestigate thetopology and the mechanism of translocation <strong>in</strong> more detail, we had acloser look at the am<strong>in</strong>o acid sequence of <strong>in</strong>vas<strong>in</strong> and <strong>in</strong>tim<strong>in</strong> us<strong>in</strong>gSignalP, PsiBLAST and HHAlign. Herefrom we got a prediction of thesignal peptide and twelve different -strands, which might build up the -barrel with<strong>in</strong> the outer membrane. Out of these predictions, we developedtopology models of the membrane anchor of <strong>in</strong>vas<strong>in</strong> and <strong>in</strong>tim<strong>in</strong>. By<strong>in</strong>troduction of HA-Tags def<strong>in</strong><strong>in</strong>g the orientation of the translocatordoma<strong>in</strong> with<strong>in</strong> the outer membrane and extensive immunofluorescencestudies, we were able to confirm our models. Furthermore, we show thatthe major periplasmic chaperone <strong>in</strong>volved <strong>in</strong> <strong>in</strong>vas<strong>in</strong> biogenesis is SurAand that DegP is responsible for quality control if <strong>in</strong>vas<strong>in</strong>.Moreover, we came to believe that <strong>in</strong>tim<strong>in</strong> (Int) and <strong>in</strong>vas<strong>in</strong> (Inv), twomajor pathogenicity factors ofE.coliandYers<strong>in</strong>ia, are monomericautotransporters, with the remarkable difference that their doma<strong>in</strong> order isreversed.MPV006Analysis of the <strong>in</strong>teraction of <strong>in</strong>vasive M1 Streptococcuspyogenes with human endothelial cellsA. Grützner*, M. Rohde, G.S. Chhatwal, S.R. TalayHelmholtz Centre for Infection Research, Medical Microbiology,Braunschweig, GermanyQuestion: Streptococcus pyogenes (GAS) is a human pathogen that causesa variety of diseases rang<strong>in</strong>g from superficial <strong>in</strong>fections to severe <strong>in</strong>vasivediseases like necrotiz<strong>in</strong>g fasciitis and streptococcal toxic shock likesyndrome. Serotype M1 and M3 GAS are most frequently associated with<strong>in</strong>vasive diseases. The M1 surface prote<strong>in</strong> is known to be a major epithelialcell <strong>in</strong>vas<strong>in</strong> and causes vascular leakage <strong>in</strong> an animal model. However, tocause an <strong>in</strong>vasive disease, the pathogen has to reach deeper tissue, afterovercom<strong>in</strong>g the endothelial cell barrier. The project focuses on the<strong>in</strong>teraction of <strong>in</strong>vasive serotype M1 S. pyogenes with human endothelialcells (EC). The aim is to identify possible pathogen- and host cellassociatedfactors that mediate barrier cross<strong>in</strong>g to elucidate the underly<strong>in</strong>gsignal<strong>in</strong>g cascades <strong>in</strong> ECs.Methods and Results: Us<strong>in</strong>g an <strong>in</strong> vitro EC <strong>in</strong>fection model we couldshow that different M1 GAS cl<strong>in</strong>ical isolates are able to <strong>in</strong>vade polarizedconfluent EC monolayers. After 3 hours of <strong>in</strong>fection streptococci colocalizewith the marker prote<strong>in</strong> Lamp-1, <strong>in</strong>dicat<strong>in</strong>g streptococcaltraffick<strong>in</strong>g <strong>in</strong>to the late endosomal/ lysosomal compartment. To testwhether streptococci conta<strong>in</strong><strong>in</strong>g phagosomes also fuse with term<strong>in</strong>allysosomes, these were pre- loaded with BSA-gold particles and analysedby transmission electron microscopy (TEM). Microscopic images reveal aclose association of streptococci with gold particles, <strong>in</strong>dicat<strong>in</strong>g fusion ofthe streptococci conta<strong>in</strong><strong>in</strong>g vacuole with term<strong>in</strong>al lysosomes. Us<strong>in</strong>g anisogenic M1 knock out mutant we demonstrate that the M1 prote<strong>in</strong> is anessential factor for the <strong>in</strong>vasion process <strong>in</strong>to ECs. Furthermore, the entry ofM1 GAS could be significantly reduced us<strong>in</strong>g antibodies purified fromrabbit M1 antiserum. Infection studies us<strong>in</strong>g M1- coated latex beadssuggest that the M1 prote<strong>in</strong> is not only essential but also can solelymediate entry <strong>in</strong>to ECs. M1- coated latex beads, just like the M1 wt stra<strong>in</strong>,traffic <strong>in</strong>to the late endosomal/ lysosomal compartment.Conclusion: Serotype M1 GAS have the potential to <strong>in</strong>vade polarizedhuman ECs. The M1 surface prote<strong>in</strong> is the EC <strong>in</strong>vas<strong>in</strong> of M1 GAS. Thus,M1 prote<strong>in</strong> is the second streptococcal factor identified to allow access<strong>in</strong>to polarized confluent ECs, one of the strongest cellular barriers <strong>in</strong> thehuman body.MPV007Lipopolysaccharides of Gram-negative bacteria contribute tothe creation of hepar<strong>in</strong>-<strong>in</strong>duced thrombocytopenia-elicit<strong>in</strong>gantibodies by b<strong>in</strong>d<strong>in</strong>g and conformationally alter<strong>in</strong>g plateletfactor 4C. Weber* 1 , K. Krauel 2,3 , A. Gre<strong>in</strong>acher 2 , S. Hammerschmidt 11 Ernst Moritz Arndt University of Greifswald, Interfaculty Institute forGenetics and Functional Genomics, Genetics of Microorganisms,Greifswald, Germany2 Ernst Moritz Arndt University of Greifswald, Institute for Immunologyand Transfusion Medic<strong>in</strong>e, Transfusion Medic<strong>in</strong>e, Greifswald, Germany3 Ernst Moritz Arndt University of Greifswald, Center for InnovationCompetence, Humoral Immune Reactions <strong>in</strong> Cardiovascular Diseases,Greifswald, GermanySome Gram-negative bacteria have been reported to contribute to theetiology of blood clott<strong>in</strong>g disorders, e.g. hepar<strong>in</strong>-<strong>in</strong>ducedthrombocytopenia (HIT) among others. HIT is an IgG-antibody-mediatedadverse drug reaction aga<strong>in</strong>st complexes of the positively-chargedchemok<strong>in</strong>e platelet factor 4 (PF4) and the most frequently used anionicanticoagulant <strong>in</strong> cl<strong>in</strong>ical medic<strong>in</strong>e, hepar<strong>in</strong>. Interest<strong>in</strong>gly, even hepar<strong>in</strong>naïvepatients are able to generate IgG-antibodies specific for PF4/hepar<strong>in</strong>complexes as soon as 4 days after exposure to hepar<strong>in</strong>, presumablybecause these patients have encountered complexes similar to PF4/hepar<strong>in</strong>before such as PF4 bound to anionic bacterial surfaces dur<strong>in</strong>g <strong>in</strong>fections.Likely candidates for negatively charged molecules on the Gram-negativesurface are prote<strong>in</strong>s as well as lipopolysaccharides (LPS).In this study pre-treatment of bacteria with prote<strong>in</strong>ases showed thatprote<strong>in</strong>s play only a m<strong>in</strong>or role <strong>in</strong> PF4 recruitment to the bacterial surface.However, the components of bacteria b<strong>in</strong>d<strong>in</strong>g PF4 have been p<strong>in</strong>po<strong>in</strong>tedby show<strong>in</strong>g that PF4 <strong>in</strong>teracts with LPS of the Gram-negative modelorganisms Escherichia coli and Salmonella typhimurium. Remarkably, E.coli and S. typhimurium mutants with successively shortened LPSbackbonedisplayed <strong>in</strong>creas<strong>in</strong>g PF4 b<strong>in</strong>d<strong>in</strong>g capacity. The highest b<strong>in</strong>d<strong>in</strong>gwas detected <strong>in</strong> the E. coli waaC and E. coli waaA mutants lack<strong>in</strong>gboth the O-antigens and parts of the core LPS. As the E. coli waaAmutant lacks <strong>in</strong> addition to the O-antigens and the <strong>in</strong>ner core heptoses alsothe 3-deoxy-D-manno-octulosonic acids (KDO) and as mono-phosphatelipid A showed a decreased b<strong>in</strong>d<strong>in</strong>g of PF4, the results suggested that thephosphate groups of lipid A are the actual structures contribut<strong>in</strong>g to PF4-b<strong>in</strong>d<strong>in</strong>g. Human PF4/hepar<strong>in</strong> antibodies could be aff<strong>in</strong>ity-purified frompatient sera us<strong>in</strong>g PF4-coated wild-type E. coli as well as PF4-coatedmutants. Thus purified antibodies tested positive <strong>in</strong> consecutivePF4/hepar<strong>in</strong> ELISA and hepar<strong>in</strong>-<strong>in</strong>duced platelet activation assays<strong>in</strong>dicated the exposition of PF4/hepar<strong>in</strong>-like epitopes on PF4-coated wildtypeE. coli and waa mutants.Hence, recruitment of PF4 to Gram-negative bacteria via lipid A and itsphosphate groups <strong>in</strong>duces epitopes on PF4 that can trigger a humoralimmune response specific for a wide variety of bacterial species.MPV008Staphylococcus epidermidis and Staphylococcus aureusQuorum Sens<strong>in</strong>g System agr Regulates Formyl PeptideReceptor 2 Ligand Secretion and thereby the Activation of theInnate Immune SystemD. Kretschmer* 1 , N. Nikola 1 , M. Duerr 1 , M. Otto 2 , A. Peschel 11 University of Tüb<strong>in</strong>gen, Institut of Medical Microbiology and InfectionMedic<strong>in</strong>e, Tüb<strong>in</strong>gen, Germany2 National Institute of Allergy and Infectious Diseases, US NationalInstitutes of Health, Bethesda, MD 20892, United StatesHighly pathogenic Staphylococcus aureus and the opportunistic pathogenStaphylococcus epidermidis secrete phenol-soluble modul<strong>in</strong> (PSM)peptides.Virulence of S. epidermidis depends mostly on the PSM peptides,which <strong>in</strong>duce chemotaxis <strong>in</strong> neutrophils and cytok<strong>in</strong>e <strong>in</strong>duction <strong>in</strong>peripheral blood mononuclearcells (PBMCs). The regulation of PSMsecretion and production occurs through the agr regulator. WhileBIOspektrum | Tagungsband <strong>2012</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!